Method Development

Based on strong research and industrial development background, Advanced Electrophoresis Solutions Ltd. (AES) is able to provide application development services to our customers.

Therapeutic Protein (Biologics and Biosimilar) Imaging CIEF Method Development

Developing and validating a new iCIEF method for biologics and biosimilar sometimes can be time consuming. This is especially true when you have developed a novel molecule. AES has developed methods for many different therapeutic recombinant proteins and peptides, monoclonal antibodies, antibody drug conjugates, and has developed specific carrier ampholytes to suit these diverse biomolecules. We can help you with our extensive expertise to speed up your product development and create great value for you.

CIEF of Herceptin reference material with with HR3-10 and HR 8-10.5 Aeslyte
iCIEF of Herceptin reference material with HR3-10 and HR 8-10.5 Aeslyte
CEInfinite Analysis of Epidermal Growth Factor Receptor Cetuximab (ADC) with HR 3-10 and SH 8-10.5
CEInfinite Analysis of Epidermal Growth Factor Receptor Cetuximab (ADC) with HR 3-10 and SH 8-10.5
CIEF of a fusion protein with SH pH 4-8 IEF solution with CEInfinite
iCIEF of a fusion protein with SH pH 4-8 IEF solution with CEInfinite
CIEF of Rituxan reference material with HR3-10 Aeslyte
iCIEF of Rituxan reference material with HR3-10 Aeslyte

Contact us to discuss your needs.